Machine Learning-Enhanced Nanoparticle Design for Precision Cancer Drug Delivery.

Area of Science:

• Nanomedicine
• Computational Biology
• Machine Learning in Oncology

Background:

• Nanoparticle (NP)-based drug delivery shows promise for targeted cancer therapy.
• Significant challenges exist in NP synthesis optimization and understanding complex in vivo nano-bio interactions.
• Current limitations hinder the full potential of nanomedicine for effective cancer treatment.

Purpose of the Study:

• To review the application of Machine Learning (ML) across the entire lifecycle of nanoparticle (NP) drug delivery systems for cancer.
• To highlight how ML can address challenges in NP design, synthesis, and in vivo performance.
• To discuss the transformative potential of ML in advancing precision cancer nanomedicine.

Main Methods:

• Review of recent advancements in ML and computational methods for nanomedicine.
• Examination of ML applications in NP synthesis and formulation.
• Analysis of ML's role in understanding and predicting nano-bio interactions (protein interactions, circulation, tumor penetration, cellular uptake).

Main Results:

• ML can accelerate the search for optimal NP synthesis parameters, streamlining formulation.
• ML models can predict and optimize NP behavior within the tumor microenvironment (TME) and during cellular internalization.
• ML facilitates a rational design approach for NPs, improving drug delivery efficiency.

Conclusions:

• Machine Learning holds significant potential to overcome current challenges in cancer nanomedicine.
• ML enables rational design of nanoparticles for enhanced drug delivery and therapeutic efficacy.
• The integration of ML is crucial for advancing precision cancer nanomedicine.